Screener
Medtronic MDT Common Stock Par Value Per Share
Common Stock Par Value Per Share at other companies
Other financials
Where this comes from
Reported directly by Medtronic in its filing.
Tagged under the XBRL concept us-gaap:CommonStockParOrStatedValuePerShare.
The source filing: Medtronic’s 10-Q, filed February 24, 2026.
- Filed
- Feb 24, 2026, 4:18 PM EST
- Fiscal quarter
- Q3 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-011107
| (in millions) | January 23, 2026 | April 25, 2025 |
|---|---|---|
| Total liabilities | 42,289 | 43,424 |
| Commitments and contingencies (Note 16) | ||
| Shareholders’ equity: | ||
| Ordinary shares— par value $0.0001, 2.6 billion shares authorized, 1,283,366,516 and 1,281,934,628 shares issued and outstanding, respectively | — | — |
| Additional paid-in capital | 21,012 | 20,833 |
| Retained earnings | 32,303 | 31,476 |
| Accumulated other comprehensive loss | (4,330) | (4,284) |
| Total shareholders’ equity | 48,985 | 48,024 |
Item 1. Financial Statements
FAQ
- What is Medtronic's common stock par value per share?
- Medtronic (MDT) reported common stock par value per share of $0.00 in Q4 2025.
- How has Medtronic's common stock par value per share changed year-over-year?
- Medtronic's common stock par value per share decreased by 0.0% year-over-year, from $0.00 to $0.00.
- What is the long-term trend for Medtronic's common stock par value per share?
- Over 4 years (2021 to 2025), Medtronic's common stock par value per share has grown at a 0.0% compound annual growth rate (CAGR), from $0.00 to $0.00.
- What does common stock par value per share mean?
- The par value of common stock is the arbitrary legal value assigned to each share of common stock at the time of issuance. It is a legacy accounting requirement that has little impact on the actual market value or trading price of the shares.
Ask your AI about Medtronic's common stock par value per share.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude